Clarithromycin-based triple therapy for Helicobacter pylori treatment in peptic ulcer patients
Introduction: The scheme proton pump inhibitor/amoxicillin/clarithromycin (PPI/AC) is still the first-line treatment for Helicobacter pylori (H. pylori) infections despite evidence suggesting its failure in up to 20% to 30% of patients. Methodology: This study involved 493 patients who were prescrib...
שמור ב:
| Main Authors: | , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | אנגלית |
| יצא לאור: |
2010
|
| גישה מקוונת: | https://doi.org/10.3855/jidc.911 https://jidc.org/index.php/journal/article/download/21252448/463 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|